Synopsys, Inc. (SNPS) rises 8.6% on growth outlook
Synopsys, Inc. (SNPS) rises after Investor Day details a stronger long-term growth plan, including about 15% FY2027 revenue growth and a path to 50% operating margins by FY2030. Heavy volume, analyst target hikes, and solid recent earnings added to the rally.
Synopsys, Inc. (SNPS) rises sharply after its Investor Day gave investors a clearer long-term growth framework, including roughly 15% FY2027 revenue growth and a path toward 50% operating margins by FY2030. The stock also benefited from heavy trading volume, analyst price-target increases, and continued confidence in Synopsys’ earnings momentum and competitive position. For investors, the rally signals stronger conviction in the story, but the premium valuation means execution now matters more than ever.
Synopsys, Inc. (SNPS) rises 8.56% to $472.15 in regular trading on Oct. 1, 2026, while volume runs at 1.7x its 200-day average. The move follows the company’s Sept. 30 Investor Day, where Synopsys set a roughly 15% FY2027 revenue-growth target and outlined a path toward a 50% operating margin by FY2030.
Key Takeaways
SNPS gains 8.56% to $472.15, with trading volume at 1.7x its 200-day average.
The main catalyst is Synopsys’ Sept. 30, 2026 Investor Day and its new long-term growth framework.
Management targets $11.15B in FY2027 revenue at the midpoint, about 15% year-over-year growth.
Fundamentals remain strong, with EPS beating estimates in 7 of the last 8 reported quarters.
The 75.9 P/E multiple supports a quality-growth valuation, but it also raises the cost of execution mistakes.
What Is Behind the Synopsys Stock Rally Today
The clearest catalyst is Synopsys’ 2026 Investor Day in New York City on Sept. 30. The company presented a multi-year financial model instead of relying only on its next quarterly result. That distinction matters because long-term guidance can change how investors value a growth company.
Synopsys expects FY2027 revenue of approximately $11.15B at the midpoint, representing about 15% growth from the prior year. It also outlined mid-teens growth through 2030 and an FY2030 operating margin near 50%. Those figures give investors a clearer earnings path after concerns about acquisition integration and the pace of future growth.
The trading action supports an event-driven repricing. SNPS moved through an intraday range of $441.75 to $493.10, while volume reached 1.7x its 200-day average. A wide range combined with heavy turnover often reflects a sharp change in expectations rather than a routine drift.
Analyst actions added fuel on Oct. 1. Deutsche Bank raised its price target from $590 to $640, KeyBanc lifted its target from $600 to $605, and Wells Fargo increased its target from $475 to $540. Headlines also highlighted new Synopsys partnerships with OpenAI and Amazon, strengthening the company’s artificial intelligence narrative.
Recent earnings support the bullish reaction. On Aug. 26, Synopsys reported EPS of $2.85 against an estimate of $2.66, a 7.1% surprise. The company has beaten EPS estimates in 7 of its last 8 reported quarters, with the only miss occurring on Sept. 9, 2025.
The stock data lists EPS at $5.73, a market value of $90.41B, and a P/E ratio of 75.9. That multiple places SNPS firmly in the premium-growth category. Investors are paying for durable expansion, strong customer retention, and the possibility that the Ansys combination will widen the company’s earnings base.
However, a premium valuation changes the risk profile. A 75.9 P/E leaves less room for weaker growth, delayed synergies, or margin pressure. The 8.56% one-day gain also means momentum has moved quickly. A disciplined approach favors staged exposure over treating one strong session as proof that every future target will be reached.
Why Synopsys Has a Durable EDA Competitive Position
Synopsys operates in electronic design automation, or EDA, and semiconductor intellectual property. Its products support digital and custom integrated-circuit design, verification, simulation, emulation, FPGA development, physical design, and manufacturing analytics.
This business has structural advantages. EDA tools sit deep inside chip-development workflows, and customers face switching costs after building design processes around them. Qualification cycles, technical integration, and the need for reliable verification make these tools difficult to replace quickly.
Synopsys is one of the two dominant EDA providers, alongside Cadence. Its broad product coverage lets it serve more stages of the chip-development process, while its design IP business adds another source of customer engagement. That competitive position helps explain why the market treats SNPS as a long-duration compounder rather than a standard software vendor.
The Ansys combination expands that positioning into simulation and multiphysics. Management expects revenue synergies from the combination to begin in 2027. AI-driven engineering, advanced packaging, and increasingly complex chip designs provide additional demand drivers. Still, integration complexity and the acquisition’s debt burden remain material risks to the investment case.
SNPS Stock Outlook After the Investor Day Repricing
The forward case now rests on measurable targets. Synopsys must convert the $11.15B FY2027 revenue midpoint into operating results, maintain mid-teens growth through 2030, and move toward the projected 50% operating margin. The planned 2027 Ansys revenue synergies add another execution test.
For investors, the central distinction is between business quality and entry price. Synopsys has strong competitive positioning, a 7-of-8 EPS beat record, and a detailed long-term growth plan. Yet the 75.9 P/E and rapid 8.56% advance demand valuation discipline. A staged approach can preserve exposure to the AI and semiconductor-design opportunity without assuming that a favorable Investor Day removes execution risk.
SNPS rises today because the market received a clearer case for sustained growth, expanding margins, and Ansys-related synergies. The move has credible fundamental support, but the premium multiple means future results must keep pace with the newly elevated expectations.
SNPS is up because Synopsys used its Investor Day to outline a stronger long-term growth plan, including about 15% FY2027 revenue growth and a path to 50% operating margins by FY2030. Analyst price-target increases and heavy trading volume also helped fuel the move.
+Should I buy SNPS stock now?
Synopsys has strong fundamentals and a credible growth outlook, but the stock already trades at a premium valuation. Investors may want to use a staged approach rather than chasing the one-day move.
+What was the main catalyst for Synopsys shares?
The main catalyst was Synopsys’ Sept. 30 Investor Day, where management laid out a multi-year financial framework. That included FY2027 revenue guidance, mid-teens growth through 2030, and a target for roughly 50% operating margins.
+Is SNPS still a quality growth stock after this rally?
Yes, Synopsys still looks like a quality growth stock because of its dominant EDA position, strong earnings track record, and long-term demand drivers. The key risk is that the higher valuation leaves less room for execution missteps.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on SNPS?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
